Last edition
News about "Diltiazem Hydrochloride Tablets"
Alembic Pharmaceuticals Receives USFDA Final Approval for Diltiazem Hydrochloride Tablets
Alembic Pharmaceuticals has received final approval from the USFDA for its Diltiazem Hydrochloride Tablets in multiple strengths, a generic version of Cardizem used for managing certain types of angina. The approval adds to the company’s growing US portfolio, bringing its total ANDA count to 230, including 210 final and 20 tentative approvals.
Diltiazem Hydrochloride Tablets | 18/11/2025 | By Dineshwori | 117
Zydus Secures Final USFDA Approval for Diltiazem Hydrochloride Tablets
Zydus Lifesciences has received final USFDA approval to market Diltiazem Hydrochloride Tablets in 30 mg, 60 mg, 90 mg, and 120 mg dosages for the treatment of chronic stable angina and angina due to coronary artery spasm in the US.
Diltiazem Hydrochloride Tablets | 11/08/2025 | By Mrinmoy Dey | 169
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy